Search results
Results From The WOW.Com Content Network
Plasmodium berghei is a single-celled parasite causing rodent malaria.It is in the Plasmodium subgenus Vinckeia.. Originally, isolated from thicket rats in Central Africa, P. berghei is one of four Plasmodium species that have been described in African murine rodents, the others being P. chabaudi, P. vinckei, and P. yoelii.
Bulletin of Sciences 4, no. 1 (1988): 14-17. Rajagopalan P.K: Malaria and Its Control in India. Health for Millions (1988): 6-8. Rajagopalan P. K, S. P Pani, P. K Das, and P Jambulingam. Malaria in Koraput District of Orissa. Indian Journal of Pediatrics 56, no. 3 (1989): 355-64. Rajagopalan P. K, and P. K Das. Problems of Malaria Control in ...
In 1880, Alphonse Laveran discovered that the causative agent of malaria is a parasite. [2] Detailed work of Golgi in 1886 demonstrated that in some patients there was a relationship between the 72-hour life cycle of the parasite and the chill and fever patterns in the patient. [2] The same observation was found for parasites with 48-hour ...
[28]: 436 The research became a foundation for a scientific theory called Haldane's decompression model. [29] He studied mathematics and classics at New College, Oxford, and obtained first-class honours in mathematical Moderations in 1912. He became engrossed in genetics and presented a paper on gene linkage in vertebrates in
The Malaria Research Project was primarily conducted on a floor of the prison hospital in the Stateville Penitentiary. The study aimed to understand the effect of various antimalarial drugs on relapses of malaria, primarily from the 8-aminoquinoline group of compounds. The study marked the first human test of the antimalarial drug primaquine. [6]
Malaria is a mosquito-borne infectious disease that affects vertebrates and Anopheles mosquitoes. [6] [7] [3] Human malaria causes symptoms that typically include fever, fatigue, vomiting, and headaches. [1] [8] In severe cases, it can cause jaundice, seizures, coma, or death.
The logo of the Drugs for Neglected Diseases initiative (DNDi) The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness (human African trypanosomiasis, HAT), Chagas disease, [1] malaria, filarial ...
His contributions to malaria research over an 18-year period began in Australia at the Walter and Eliza Hall Institute of Medical Research, then continued as a tenured Principal Investigator at the National Institutes of Health (NIH) in Bethesda, MD, USA, and continued at the biotechnology companies DNAX (now Schering-Plough Biopharma) and ...